Tirzepatide represents a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://idaqwqt881495.blogadvize.com/48977189/tirzepatide-a-new-frontier-in-diabetes-treatment